Release Summary

Hanmi presented the result of non-clinical ‘LAPSInsulin Combo’ at 75th ADA. Once weekly ‘Insulin+ GLP-1’ combination offered better glycemic control and lowered hypoglycemia and weight gain risk .

Hanmi Pharmaceutical Co., Ltd.